
Built for insulin sensitivity
Metformin lowers the glucose your liver releases and helps your cells respond to insulin, the metabolic effects it is best known for.









The people pictured are models, not patients.
RxLongevity
The metabolic workhorse, prescribed.
40,000+ products sold · LegitScript certified
Metformin ER 500 mg in an oral extended-release tablet. Explore liver glucose production, insulin sensitivity and the differences from GLP-1 medications.
Explore the ingredients and compare options →Pause, change, or cancel anytime from your account.
How Would You Like To Pay?
Choose Your Plan
Or pay with
$134 billed today, then every month until canceled.
Not prescribed? Full refund.
After checkout you complete a short medical review in your member portal, and a US-licensed provider reviews it before your metformin ER ships.
Full refund if not prescribed Free, discreet shipping Cancel anytime
Order today and here is what happens next
Common questions

Breakfast
The people pictured are models, not patients.

Metformin lowers the glucose your liver releases and helps your cells respond to insulin, the metabolic effects it is best known for.

The extended-release form is taken once a day with food and is gentler on your stomach than immediate-release.

Metformin is one of the most prescribed and best studied medicines in the world, with a long safety record.

A US-licensed provider reviews your history and labs and prescribes metformin off-label for metabolic health only if it fits you.
How we compare
Meet the formula
Metformin has a specific metabolic identity: it is a biguanide medication that affects glucose regulation. The HealthRX.com listing is metformin ER 500 mg, an extended-release oral tablet. Its product story begins with glucose production by the liver, glucose handling and insulin sensitivity. Those mechanisms distinguish it from semaglutide and tirzepatide, which act through incretin-receptor pathways. Understanding the differences makes an oral metabolic option easier to evaluate than grouping every product under weight loss or longevity.

Reduced hepatic glucose production
Effects on intestinal absorption and insulin sensitivity
500 mg extended-release oral tablet
Inside the formula
ER 500 mg
Metformin belongs to the biguanide family. Its established pharmacology includes decreasing glucose production by the liver, decreasing intestinal glucose absorption and improving insulin sensitivity. Those actions concern how the body produces and handles glucose. The ER designation belongs to the tablet formulation, while 500 mg identifies the listed strength. Together they distinguish this product from immediate-release metformin and from injectable incretin medications.
A closer look / 01
Blood glucose comes from more than the carbohydrate in a meal. The liver also produces glucose, including during periods without food. Metformin’s action on hepatic glucose production is therefore an important part of its metabolic explanation. Insulin sensitivity concerns how tissues respond to insulin, another piece of glucose regulation. These connected processes give the medication a more specific identity than a general metabolism label.
A glucose measurement, a change in body weight and a broad question about aging are different endpoints. Understanding the pathway helps you keep them distinct when reading research or comparing products. Metformin’s diabetes evidence concerns defined metabolic populations and outcomes; longevity research asks additional questions of its own.
A closer look / 02
Extended release describes a formulation designed to release the active ingredient over an extended period. It is a property of the tablet, separate from the identity of metformin itself. Immediate-release and extended-release products can share the active ingredient while differing in their formulation and product instructions. The current listing identifies ER 500 mg and a 180-tablet catalog quantity.
Tablet strength and container quantity answer different questions. The strength tells you how much metformin is in a listed tablet. The quantity tells you the number of tablets in the catalog option. Neither number should be substituted for an individualized schedule; the purchase listing and the treatment instructions each have their own role.
A closer look / 03
Semaglutide is a GLP-1 receptor agonist. Tirzepatide activates GIP and GLP-1 receptors. Metformin is a biguanide with a different pharmacologic explanation. The HealthRX.com options also differ in format, with oral metformin tablets and injectable incretin products. That is a meaningful comparison of active ingredient, target and delivery, rather than assuming one product is a tablet version of another.
A closer look / 04
The Diabetes Prevention Program compared metformin, an intensive lifestyle intervention and placebo in people at elevated risk of diabetes. It measured the development of diabetes, a specific outcome in a specific population. That study provides important metabolic context. A claim about extending human lifespan would require a different endpoint, which is why the actual research question belongs in any explanation of metformin’s wider scientific interest.
Make an informed comparison
Compare ingredient family, mechanism and format together. Metformin’s glucose-regulation pathway and ER oral tablet distinguish it from the injectable GLP-1 and dual GIP/GLP-1 products. The category name alone leaves those important differences out.
| Option | Ingredient identity | What distinguishes it |
|---|---|---|
| Metformin ER | Metformin | Biguanide; extended-release oral tablet |
| Semaglutide | Semaglutide | GLP-1 receptor agonist; injectable product |
| Tirzepatide | Tirzepatide | GIP / GLP-1 receptor agonist; injectable product |
The useful details
ER means extended release. The active ingredient remains metformin; the release formulation differs. Reading the ingredient, the release designation and the listed strength separately gives a clearer picture of the actual tablet.
They are different molecules in different medication families. Metformin is a biguanide; semaglutide is a GLP-1 receptor agonist. They also have different product formats in this catalog. A shared metabolic-care category does not make their pathways interchangeable.
Explore the ingredient research
See the available product options.
View optionsHealthRX.com verified facts
Metformin ER starts at $107 per month on 12-month plan; the lowest checkout charge is $134 (billed monthly). A prescription is never guaranteed. A licensed provider reviews each request before a pharmacy can dispense treatment.
Catalog verified August 26, 2026. Source: HealthRX.com checkout catalog and refund policy. Monthly equivalent divides the discounted plan charge by the number of months; checkout may collect a multi-month total.

Choose your treatment options and complete secure checkout. Then complete the online health intake.
A US-licensed provider reviews your history and, if appropriate, prescribes metformin ER off-label.
Your metformin ships to your door in 3 to 5 days.
Message your provider and adjust your dose over time.
Metformin is one of the most-prescribed and best-understood medications in the world, and its effect on insulin sensitivity and metabolism has made it a fixture of longevity interest. The extended-release form is gentler on the stomach. Reviewed by a licensed provider, dispensed by a US-licensed pharmacy.
Metformin reduces hepatic glucose output and improves insulin sensitivity, partly via AMPK activation. Dispensed by a US-licensed pharmacy.
Less glucose from your liver
Metformin reduces the amount of glucose your liver sends into your blood.
Better insulin response
Your muscle and fat cells take up glucose more efficiently.
Lower insulin load
With steadier glucose, your body needs less circulating insulin.
Steadier blood sugar and improved insulin sensitivity, the metabolic effects that put metformin at the center of longevity research.
Metformin has one of the deepest human evidence bases in medicine for blood sugar and insulin sensitivity. Its use for healthy aging is now being formally studied in the TAME trial, which is ongoing and has not yet reported. The results below reflect what large human trials have shown for metabolic outcomes, not for longevity.
31%
Lower risk of developing type 2 diabetes versus placebo over 2.8 years in 3,234 adults at high risk.
Knowler et al., New England Journal of Medicine, 2002
18%
Lower diabetes incidence versus placebo sustained across 10 years of follow-up in the same cohort.
Diabetes Prevention Program Outcomes Study, Lancet, 2009
Why we prescribe the extended-release form
| Metformin ER | Immediate-release metformin | |
|---|---|---|
| How it is released | Slowly, over hours | All at once |
| Stomach upset | Less common | More common early on |
| Daily doses | Usually one | Two to three |
| Glucose lowering | Equivalent | Equivalent |
| Lowest cost | Slightly higher | Lowest |
| Best for | A simple, gentle routine | Cost-focused, tolerant stomachs |
Some stomach upset is possible early and eases with the extended-release form and taking it with food. Your provider sets the dose.
Week 1 to 2
Begin at a low dose taken with food to ease your stomach.
Week 2 to 4
Your provider steps the dose up as you tolerate it.
Month 1 to 3
Early stomach effects usually fade on the extended-release form.
Ongoing
Your provider reviews your labs and adjusts over time.
Reviewed by a licensed provider. Not used with significantly reduced kidney function (rare risk of lactic acidosis), and paused around contrast imaging or acute illness. Tell your provider about kidney function and alcohol use; B12 is monitored long term.
Metformin is started low and taken with food to limit stomach effects. Your provider checks your kidney function and may monitor vitamin B12. Tell your provider about alcohol use and any kidney or liver conditions.
No prescription needed. Dietary supplements for the daily habits around your care, sold separately from prescription treatment. Ask your provider before adding one to your routine.
Dietary supplements, not medications. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

An independent US-licensed clinician reviews every request. If they decide the treatment is not right for you, you get a full refund for the medication.
Prescriptions are filled by a US-licensed pharmacy and shipped free, in discreet packaging, on every plan.
LegitScript-certified · Cert 50087439
Compounded medications are prepared by a US-licensed pharmacy and are not reviewed by the FDA for safety or effectiveness. Products are dispensed only after a licensed provider determines they are appropriate. Information here is educational and is not a substitute for medical advice.